Cincinnati, OHNCT07135895Now EnrollingIRB Ready

Acute Lower Limb Arterial Occlusion Clinical Trial in Cincinnati, OH

Access cutting-edge acute lower limb arterial occlusion treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by Inari Medical

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access acute lower limb arterial occlusion specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute lower limb arterial occlusion treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this acute lower limb arterial occlusion clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Acute Lower Limb Arterial Occlusion Study in Cincinnati

This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.

Sponsor: Inari Medical

Who Can Participate

Inclusion Criteria

Age ≥ 18 years
Acute symptom duration ≤ 14 days
Lower limb arterial occlusion below inguinal ligament
Target lesion in native vessel
Target vessel size between 3 mm and 8 mm by visual estimation
Rutherford category I, IIa, or IIb
Informed consent is obtained from either patient or legally authorized representative (LAR) per Institutional Review Board/Ethics Committee requirements

Exclusion Criteria

Life expectancy \< 6 months
Prior major amputation in the target limb
Prior minor amputation in the target limb that is not completely healed or cannot bear weight
Non-thrombotic occlusion secondary to dissection, vasculitis, or target vessel trauma
Treatment of the index event in the target vessel with any other endovascular thrombectomy/aspiration or open surgical method prior to Artix procedure
Part of a vulnerable population (e.g., currently pregnant, breastfeeding or incarcerated) per local definitions
Known sensitivity to radiographic contrast agents that, in the Investigator's opinion, cannot be adequately pre-treated
Unable to tolerate antiplatelet therapy
Inability to anticoagulate the patient with heparin, enoxaparin or other parenteral antithrombin, or known to have uncorrected bleeding disorders (e.g., gastro-intestinal ulcer, menorrhagia, liver failure, heparin-induced thrombocytopenia (HIT))
Any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject (e.g., contraindication to use of Artix per local approved labeling, compromise the well-being or that could prevent, limit, or confound the protocol-specified assessments)
Current participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT07135895) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Lower Limb Arterial Occlusion Treatment Options in Cincinnati, OH

If you're searching for acute lower limb arterial occlusion treatment options in Cincinnati, OH, this clinical trial (NCT07135895) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute lower limb arterial occlusion specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH